Form D · Pharmaceuticals

Expansion Therapeutics, Inc.

Jupiter, FL · CIK 0001691275

Offering snapshot reported Oct 12, 2021 · SEC filing

Reported sold
$48M
Offering amount: $80.1M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 27, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 12, 2021Initial$48,032,016No comparison12SEC filing
Jan 3, 2018Initial$25,305,863No comparison8SEC filing
Jun 2, 2017Amendment$5,000,000$4,750,000vs Dec 6, 20163SEC filing
Dec 6, 2016Initial$250,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-416540

Source: Form D, filed Oct 12, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matthew Disney Director
Matthew Disney, Ph.D. Director
Kevin Forrest Director, Executive
Kevin Forrest, Ph.D. Director, Executive
Jason Hafler Director
Jason Hafler, Ph.D. Director
Yujiro Hata Director
Yujiro Hata, M.B.A. Director
Campbell Murray, M.B.B.S., M.B.A. Director
Andy Phillips, Ph.D. Director
Scott Rocklage Director, Executive
Scott Rocklage, Ph.D. Director
Beth Seidenberg, M.D. Director
Renato Skerlj, Ph.D. Director, Executive
Paul Stone Executive
Laura Tadvalkar, Ph.D. Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
555 Heritage Drive, Suite 150
Jupiter, FL, 33458